EICHOR
● Enrolling By Invitation
Long-term Safety and Tolerability of BHV-7000
Condition: Focal Epilepsy · Sponsor: Biohaven Therapeutics Ltd.
About this study
A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (283)
| Accel Research | Birmingham, Alabama, United States | — |
| Onyx Clinical Trials | Peoria, Arizona, United States | — |
| Xenoscience, Inc. | Phoenix, Arizona, United States | — |
| University of Arizona / Banner University Medical Center Phoenix | Phoenix, Arizona, United States | — |
| Barrow Neurological Institute | Phoenix, Arizona, United States | — |
| ARENSIA Exploratory Medicine | Phoenix, Arizona, United States | — |
| Center for Neurosciences | Tucson, Arizona, United States | — |
| Clinical Trials, Inc. | Little Rock, Arkansas, United States | — |
| WRN | Rogers, Arkansas, United States | — |
| University of California San Diego | La Jolla, California, United States | — |
| Amicis Research Center | Lancaster, California, United States | — |
| Memorialcare Miller Children's & Women's Hospital Long Beach | Long Beach, California, United States | — |
+ 271 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06443463